Breaking News Instant updates and real-time market news.

FITB

Fifth Third

$27.37

-0.17 (-0.62%)

, MCO

Moody's

$112.66

0.39 (0.35%)

04:55
03/08/17
03/08
04:55
03/08/17
04:55

RBC Capital to hold a conference

Financial Institutions Conference is being held in New York on March 7-8.

FITB

Fifth Third

$27.37

-0.17 (-0.62%)

MCO

Moody's

$112.66

0.39 (0.35%)

CMA

Comerica

$72.63

-0.62 (-0.85%)

STL

Sterling Bancorp

$23.85

-1.2 (-4.79%)

RF

Regions Financial

$15.19

0.02 (0.13%)

PODD

Insulet

$44.71

1.04 (2.38%)

PNC

PNC Financial

$127.40

-0.19 (-0.15%)

C

Citi

$60.50

0.22 (0.36%)

HOMB

Home Bancshares

$28.53

-0.15 (-0.52%)

WTFC

Wintrust Financial

$73.27

-0.47 (-0.64%)

PRG

Physicians Resource Group

USB

U.S. Bancorp

$55.03

-0.26 (-0.47%)

AINV

Apollo Investment

$6.44

-0.07 (-1.08%)

HTGC

Hercules Capital

$14.82

-0.03 (-0.20%)

MTB

M&T Bank

$166.73

-0.24 (-0.14%)

MAIN

Main Street

$36.99

-0.01 (-0.03%)

BPOP

Popular

$42.77

-0.8 (-1.84%)

  • 08

    Mar

  • 14

    Mar

  • 15

    Mar

  • 15

    Mar

  • 20

    Mar

  • 13

    Apr

  • 13

    Apr

  • 19

    Apr

  • 25

    Apr

  • 25

    Apr

  • 03

    May

  • 15

    May

  • 19

    Jul

  • 18

    Oct

  • 17

    Jan

FITB Fifth Third
$27.37

-0.17 (-0.62%)

03/02/17
HDLY
03/02/17
DOWNGRADE
HDLY
Underperform
Fifth Third downgraded to Underperform from Neutral at Hilliard Lyons
03/03/17
EVER
03/03/17
DOWNGRADE
EVER
Underperform
Fifth Third downgraded to Underperform from Hold at Evercore ISI
03/07/17
RAFF
03/07/17
DOWNGRADE
RAFF
Hold
Fifth Third downgraded to Hold from Buy at Rafferty Capital
Rafferty Capital's Dick Bove downgraded Fifth Third to Hold from Buy.
01/25/17
HDLY
01/25/17
UPGRADE
HDLY
Neutral
Fifth Third upgraded to Neutral from Underperform at Hilliard Lyons
MCO Moody's
$112.66

0.39 (0.35%)

01/10/17
LEHM
01/10/17
DOWNGRADE
Target $100
LEHM
Equal Weight
Moody's downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Manav Patnaik downgraded Moody's to Equal Weight saying issuance could be pressured by rising interest rates and tax reform while the Department of Justice overhang limits buybacks. The analyst lowered his price target for the shares to $100 from $120.
01/10/17
01/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Moody's (MCO) was downgraded to Equal Weight from Overweight at Barclays and to Neutral from Buy at UBS. 2. Goldman Sachs (GS) and Comerica (CMA) were downgraded to Sell from Neutral at Citi. 3. T-Mobile (TMUS) downgraded to Neutral from Buy at MoffettNathanson. 4. AMAG Pharmaceuticals (AMAG) downgraded to Market Perform from Outperform at Leerink and to Neutral from Buy at Janney Capital. 5. BP (BP) downgraded to Market Perform from Outperform at BMO Capital analyst Brendan Warn citing his belief that the company will make a major acquisition this year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/17
UBSW
01/10/17
DOWNGRADE
Target $99
UBSW
Neutral
Moody's downgraded to Neutral from Buy at UBS
UBS analyst Alex Kramm downgraded Moody's to Neutral saying the company's 2017 guidance in a few weeks will likely miss consensus estimates. Potential headwinds from tax reform and higher interest rates are not fully priced into the stock's current valuation, Kramm tells investors in a research note. He lowered his price target for the shares to $99 from $116. Barclays this morning also downgraded Moody's.
02/21/17
MSCO
02/21/17
DOWNGRADE
Target $114
MSCO
Equal Weight
Moody's downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Toni Kaplan downgraded Moody's to Equal Weight and raised its price target to $114 from $112. Kaplan believes valuation reflects strong issuance expectations for 2017 and does not fully discount difficult 2H comps and potential headwinds from the elimination of interest deductibility and other regulatory changes.
CMA Comerica
$72.63

-0.62 (-0.85%)

02/17/17
JEFF
02/17/17
NO CHANGE
Target $87
JEFF
Buy
Comerica priice target raised to $87 from $74 at Jefferies
Jefferies analyst Ken Usdin raised his price target for Comerica to $87 after meeting with management and keeps a Buy rating on the shares. The company is well positioned for "solid" earnings growth and higher profitability due to benefits from rate-sensitivity, efficiency gains, and capital strength, the analyst contends.
01/10/17
SBSH
01/10/17
DOWNGRADE
Target $65
SBSH
Sell
Comerica downgraded to Sell from Neutral at Citi
Citi analyst Keith Horowitz downgraded Comerica (GS) to Sell with a $65 price target. The rise in interest rates seem more than priced in at current levels, Horowitz tells investors in a research note. The analyst believes U.S. bank stocks do not offer compelling risk/reward profiles following the recent rally.
01/10/17
SBSH
01/10/17
DOWNGRADE
Target $225
SBSH
Sell
Goldman Sachs downgraded to Sell from Neutral at Citi
Citi analyst Keith Horowitz downgraded Goldman Sachs (GS) to Sell with a $225 price target, representing 6% downside from current levels. While higher interest rates benefit fixed income trading, the path is "relatively uncertain and the bar is relatively high" for Goldman, Horowitz tells investors in a research note. The analyst believes U.S. bank stocks do not offer compelling risk/reward profiles following the recent rally. Horowitz this morning also downgraded Comerica (CMA) to Sell while keeping Buy ratings on Wells Fargo (WFC) and Bank of America (BAC).
STL Sterling Bancorp
$23.85

-1.2 (-4.79%)

01/09/17
HOVD
01/09/17
DOWNGRADE
HOVD
Market Perform
Sterling Bancorp downgraded to Market Perform from Outperform at Hovde Group
01/11/17
PIPR
01/11/17
UPGRADE
Target $25.5
PIPR
Overweight
Sterling Bancorp upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Matthew Breese upgraded Sterling Bancorp to Overweight saying the company is one of the most asset sensitive banks in the Northeast and is well positioned from a funding perspective. The analyst raised his price target for the shares to $25.50 from $20.
12/19/16
MAXM
12/19/16
NO CHANGE
MAXM
Maxim raises FY17 estimates, targets for several regional banks
Maxim analyst Michael Diana raised his price targets and 2017 EPS estimates for a number of small to mid-cap regional banks - including Access National (ANCX), Cullen/Frost (CFR), ConnectOne Bancorp (CNOB), Customers Bancorp (CUBI), First Community Financial Partners (FCFP), First Republic (FRC), County Bancorp (ICBK), M B T Financial (MBTF), Nicolet Bankshares (NCBS), QCR Holdings (QCRH), SVB Financial (SIVB), Sterling Bancorp (STL) TriState Capital (TSC) - citing interest rate hikes and rising valuations amid expectations for faster economic growth and lower regulatory burdens. He notes, however, that his revised 2017 EPS estimates assume fewer than three Fed rate hikes in 2017.
11/16/16
PIPR
11/16/16
DOWNGRADE
Target $20
PIPR
Neutral
Sterling Bancorp downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Matthew Breese downgraded Sterling Bancorp to Neutral citing valuation following the recent rally in the shares. The analyst keeps a $20 price target for the shares.
RF Regions Financial
$15.19

0.02 (0.13%)

02/16/17
RHCO
02/16/17
UPGRADE
Target $18
RHCO
Buy
Regions Financial upgraded to Buy from Hold at SunTrust
SunTrust analyst Jennifer Demba upgraded Regions Financial to Buy and increased its price target to $19 from $15. Demba commented that the significant cultural transformation over the last few years appears to be underappreciated. The analyst expects the P/TBV discount to narrow as profitability improves and outsized capital returns continue. She expects management's prudent lending decisions to result in 12%-14% ROTCE by 2018 and improve investor sentiment.
01/23/17
01/23/17
DOWNGRADE

Neutral
Regions Financial downgraded to Neutral challenging loan growth at Compass Point
As previously reported, Compass Point downgraded Regions Financial to Neutral from Buy and raised its price target to $15 from $14.50. Analyst Scott Valentine said FY17 guidance was weaker than expected, driving his operating earnings estimates lower and said loan growth remains challenging.
03/01/17
SPHN
03/01/17
DOWNGRADE
SPHN
Equal Weight
Regions Financial downgraded to Equal Weight from Overweight at Stephens
03/01/17
03/01/17
DOWNGRADE

Equal Weight
Regions Financial downgraded to Equal Weight at Stephens
As previously reported, Stephens analyst Terry McEvoy downgraded Regions Financial to Equal Weight from Overweight on valuation.
PODD Insulet
$44.71

1.04 (2.38%)

02/28/17
LEER
02/28/17
NO CHANGE
Target $60
LEER
Outperform
Insulet price target raised to $60 from $50 at Leerink
Leerink analyst Danielle Antalffy raised her price target for Insulet to $60 from $50 after the company delivered "another strong quarter of outperformance," coming in ahead of expectations in all key businesses. The analyst believes Insulet is shaping up to be "one of the cleanest execution stories" within her SMID-cap coverage universe. She reiterates an Outperform rating on the shares.
02/27/17
FLTL
02/27/17
DOWNGRADE
FLTL
Hold
Insulet downgraded to Hold from Buy at Feltl
03/06/17
BTIG
03/06/17
DOWNGRADE
BTIG
Neutral
Insulet downgraded to Neutral from Buy at BTIG
BTIG analyst Sean Lavin downgraded Insulet to Neutral given the strong run in shares.
02/28/17
BARD
02/28/17
NO CHANGE
Target $49
BARD
Outperform
Insulet weakness a buying opportunity, says Baird
Baird analyst Jeff Johnson said Insulet posted solid Q4 results and as a result sees the weakness following the results a s buying opportunity. Johnson cited the better than expected revenues from its U.S. Omnipod and drug delivery. Johnson also noted the company's growing pipeline. Johnson reiterated his Outperform rating and raised his price target to $49 from $47 on Insulet shares.
PNC PNC Financial
$127.40

-0.19 (-0.15%)

02/08/17
GSCO
02/08/17
UPGRADE
Target $143
GSCO
Conviction Buy
PNC Financial upgraded to Conviction Buy from Neutral at Goldman
Goldman Sacs analyst Richard Ramsden upgraded PNC Financial to Conviction Buy from Neutral saying the bank will benefit from balance sheet growth amid higher interest rates. PNC's rate opportunity is underappreciated as consensus estimates are "mis-modeling" its net interest income growth, Ramsden tells investors in a research note. He raised his price target for the shares to $143 from $121.
01/17/17
MACQ
01/17/17
UPGRADE
Target $135
MACQ
Outperform
PNC Financial upgraded to Outperform from Neutral at Macquarie
Macquarie analyst David Konrad upgraded PNC Financial to Outperform and raised its price target to $135 from $128. The analyst expects the "re-emergence" of top-line growth and strong operating leverage to re-rate shares from the 3% discount to a modest premium to peers. Konrad said PNC's leverage and potential for redeployment in an improving economy and better rates should provide better risk adjusted returns.
03/02/17
HDLY
03/02/17
DOWNGRADE
HDLY
Underperform
PNC Financial downgraded to Underperform from Neutral at Hilliard Lyons
01/17/17
RBCM
01/17/17
NO CHANGE
RBCM
PNC Financial reported 'solid' results, says RBC Capital
RBC Capital analyst Gerard Cassidy says that PNC reported "solid results," with "modest revenue growth and controlled core expenses." The analyst thinks that the bank "is well-positioned for higher interest rates." He keeps a $130 price target and a Top Pick rating on the stock.
C Citi
$60.50

0.22 (0.36%)

02/01/17
BERN
02/01/17
NO CHANGE
BERN
Citi Mexico exposure appears 'manageable,' says Bernstein
Noting that the Trump Administration is in the process of changing U.S. policies towards Mexico, Bernstein analyst John Mcdonald reports that Citi obtains 8%-9% of its revenue from the country. Still, the analyst believes that Citi's exposure to Mexico "looks manageable, short of a severe economic pullback in the region." McDonald says that Citi's "diversified international exposure and Banamex's long history of operating successfully in Mexico" limit the bank's risk in the country. He keeps a $68 price target and an Outperform rating on the shares.
02/01/17
MSCO
02/01/17
NO CHANGE
MSCO
Overweight
Citi offers most compelling value, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck, said Citi is her top pick and the biggest beneficiary of financial regulation, given its complex global footprint and the largest excess capital versus in the group. Graseck believes Citi's exposure to Mexico and potential $3B in DTA writedowns are manageable and believes fully optimizing capital could drive a 20% increase in earnings. The analyst said Citi offers the most compelling value and reiterates her Overweight rating and $70 price target price target on shares.
03/03/17
EVER
03/03/17
DOWNGRADE
Target $63
EVER
In Line
Citi downgraded to In Line from Buy at Evercore ISI
Evercore ISI changed its rating system to Outperform, In Line and Underperform. Analyst Glenn Schorr said Citi has been executing well and will continue to improve but downgraded shares to In Line. He believes shares will not keep pace with large bank peers given investor preference for less EM exposure, less Mexico, better US rate leverage, and potential for book loss related to lower US tax rates. Schorr's price target on Citi goes to $63 from $62
02/02/17
SBSH
02/02/17
DOWNGRADE
Target $83
SBSH
Neutral
Citi downgrades Ralph Lauren to Neutral on CEO departure
Citi analyst Kate McShane downgraded Ralph Lauren to Neutral from Buy saying the departure of CEO Stefan Larsson feels like a "giant step back." The CEO change, coupled with a lack of transparency, brings uncertainty to the company's long-term growth strategy, McShane tells investors in a post-earnings research note. She believes finding a replacement could be challenging since the new CEO's vision still has to fit with that of Mr. Lauren. The analyst cut her price target for the shares to $83 from $114. In midday trading, Ralph Lauren is down 11%, or $9.99, to $77.38.
HOMB Home Bancshares
$28.53

-0.15 (-0.52%)

01/24/17
01/24/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tableau (DATA) upgraded to Buy from Neutral at Citi with analyst Walter Pritchard saying consensus estimates for fiscal 2017 look low. Revenue transition impacted numbers more than the Street realized in 2016, Pritchard tells investors in a research note. The analyst raised his price target for the shares to $64 from $50. 2. Agrium (AGU) upgraded to Outperform from Market Perform at Cowen, while CF Industries (CF), Mosaic (MOS), and Potash (POT) were upgraded to Market Perform from Underperform. 3. Calithera Biosciences (CALA) upgraded to Neutral from Sell at Citi with analyst Robyn Karnauskas citing her conversation with management. Management now appears more open to partnering, Karnauskas tells investors in a research note. 4. Home Bancshares (HOMB) upgraded to Buy from Hold at Sandler O'Neill. 5. Amicus (FOLD) upgraded to Outperform from Neutral at Baird with analyst Michael Ulz saying the company removed two overhangs by providing regulatory clarity for Galafold in the U.S. as well as a strengthening its balance sheet. Ulz raised his price target to $10 from $7 on Amicus shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/09/16
SPHN
12/09/16
NO CHANGE
Target $29
SPHN
Overweight
Home Bancshares price target raised to $29 from $24 at Stephens
Stephens analyst Matt Olney raised his price target for Home Bancshares to $29 from $24 to reflect the recent M&A announcements. The analyst reiterates an Overweight rating on the shares.
12/15/16
RAJA
12/15/16
DOWNGRADE
RAJA
Market Perform
Home Bancshares downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst David Long downgraded Home Bancshares to Market Perform based on valuation.
01/24/17
SDLR
01/24/17
UPGRADE
SDLR
Buy
Home Bancshares upgraded to Buy from Hold at Sandler O'Neill
WTFC Wintrust Financial
$73.27

-0.47 (-0.64%)

11/29/16
KBWI
11/29/16
UPGRADE
Target $72
KBWI
Outperform
Wintrust Financial upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Christopher McGratty upgraded Wintrust Financial to Outperform citing the company's favorable interest rate profile and "unique growth/defensive characteristics." The analyst raised his price target for the shares to $72 from $59.
12/20/16
RHCO
12/20/16
INITIATION
Target $77
RHCO
Hold
Wintrust Financial initiated with a Hold at SunTrust
SunTrust analyst Michael Young initiated Wintrust Financial with a Hold and a $77 price target.
08/24/16
HOVD
08/24/16
INITIATION
Target $59
HOVD
Market Perform
Wintrust Financial initiated with a Market Perform at Hovde Group
Hovde Group analyst Kevin Fitzsimmons initiated Wintrust Financial with a Market Perform and $59 price target.
06/10/16
PIPR
06/10/16
INITIATION
Target $52
PIPR
Neutral
Wintrust Financial initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Nathan Race started Wintrust Financial with a Neutral rating and $52 price target.
PRG Physicians Resource Group

USB U.S. Bancorp
$55.03

-0.26 (-0.47%)

12/21/16
ATLE
12/21/16
DOWNGRADE
ATLE
Neutral
U.S. Bancorp downgraded to Neutral from Overweight at Atlantic Equities
12/21/16
12/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Stifel with analyst Astrachan citing "recent negative FX movement, moderate anticipated input cost inflation, and continued heightened geopolitical uncertainty." 2. JetBlue (JBLU) downgraded to Market Perform from Outperform at Raymond James with analyst Savanthi Syth saying shares will be range bound near-term due to RASM pressures from capacity growth new market expansion, and increased cost inflation. 3. Barrick Gold (ABX) downgraded to Hold from Buy at TD Securities analyst Greg Barnes saying shares have significantly outperformed in 2016 and sees fewer company-specific catalysts in 2017. 4. New York Community Bancorp (NYCB) and Astoria Financial (AF) were downgraded to Underperform at FBR Capital. 5. Goldman Sachs (GS) and U.S. Bancorp (USB) were downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/11/17
UBSW
01/11/17
INITIATION
Target $60
UBSW
Buy
U.S. Bancorp initiated with a Buy at UBS
UBS analyst Saul Martinez started U.S. Bancorp with a Buy rating and $60 price target. The analyst calls the company his top pick in the Americas Banks sector.
12/05/16
BARD
12/05/16
NO CHANGE
BARD
Baird suggests booking banking stock gains at current levels
Baird is telling investors to book banking stock gains at current levels as the shares are already discounting significant fundamental improvement in 2017 and 2018. The firm has raised estimates on its banking coverage to reflect benefits from rate increases and sees slight upside if corporate tax rates are lowered, but they remain skeptical the economy can absorb significant Fed tightening without slowing.
AINV Apollo Investment
$6.44

-0.07 (-1.08%)

06/03/16
RHCO
06/03/16
NO CHANGE
RHCO
Higher risk BDCs look attractive, says SunTrust
SunTrust is upbeat on BDCs that are viewed as more risky, saying that their risk/reward ratio is positive. The firm says that these stocks are "highly oversold" and can rally 25%-40%, but it warns that investors in these names need "a bit more patience and risk tolerance." The firm identifies Apollo Investment (AINV), PennantPark (PNNT), and Fifth Street Finance (FSC) as riskier BDCs whose sell-off has been overdone.
06/13/16
UBSW
06/13/16
NO CHANGE
Target $7
UBSW
Buy
Apollo Investment price target lowered to $6.50 from $8.50 at UBS
UBS lowered its price target on Apollo Investment to $6.50 from $8.50 to reflect the lower NAV due to its exposure to the oil and gas sector. The firm believes shares are undervalued due to the disconnect between the book value, which is higher than the net asset value. UBS reiterated its Buy rating on Apollo Investment shares.
07/08/16
BOFA
07/08/16
DOWNGRADE
BOFA
Underperform
Apollo Investment downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded Apollo Investment to Underperform saying fundamentals are likely to remain weak near-term. The firm's analyst said Apollo's operating performance has been impacted by overweight exposure to commodities, accelerating non-accruals, falling portfolio yield, and inability to access the capital markets and views the current dividend as unsustainable.
05/20/16
05/20/16
DOWNGRADE

Hold
Apollo Investment downgraded to Hold on asset quality declines at BB&T
As previously reported, BB&T downgraded Apollo Investment to Hold from Buy. Analyst Vernon Plack sees less room for incremental credit issues and views current valuation as balanced given concerns about the long-term prospects for both NAV per share and the dividend.
HTGC Hercules Capital
$14.82

-0.03 (-0.20%)

02/24/17
02/24/17
DOWNGRADE

Market Perform
Hercules Capital downgraded on increased investments, valuation at Raymond James
As previously reported, Raymond James downgraded Hercules Capital to Market Perform from Outperform. Analyst Robert Dodd sees material "risk" of increased 2H 2017 expenditures that will negatively impact short-term earnings and said valuation is at his prior price target.
07/25/16
MACQ
07/25/16
DOWNGRADE
MACQ
Neutral
Hercules Technology downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Hugh Miller downgraded Hercules Technology to Neutral citing lack of catalysts and low probability of a dividend raise ahead of 2018. The analyst has a $13 price target on Hercules shares.
04/27/16
JANY
04/27/16
INITIATION
Target $12
JANY
Neutral
Hercules Technology resumed with a Neutral at Janney Capital
Janney Capital analyst Mitchel Penn resumed coverage of Hercules Technology with a Neutral rating and fair value estimate of $12.
02/24/17
RAJA
02/24/17
DOWNGRADE
RAJA
Market Perform
Hercules Capital downgraded to Market Perform from Outperform at Raymond James
MTB M&T Bank
$166.73

-0.24 (-0.14%)

01/11/17
UBSW
01/11/17
DOWNGRADE
Target $150
UBSW
Sell
M&T Bank downgraded to Sell from Neutral at UBS
UBS analyst David Eads downgraded M&T Bank to Sell saying the valuation is full at current levels. The analyst recommends caution in the U.S. Small and Mid-cap Commercial Banks space and raised his price target for the shares to $150 from $145.
10/06/16
WEDB
10/06/16
INITIATION
Target $117
WEDB
Neutral
M&T Bank initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated M&T Bank with a Neutral and a $117 price target.
11/11/16
RBCM
11/11/16
NO CHANGE
RBCM
Banks to benefit from higher interest rates, says RBC Capital
RBC Capital believes that the Fed is committed to raising interest rates, and it expects FOMC members' forecast to show they expect two rate increases to occur in 2017. The firm expects higher rates to boost banks' net interest margin, raising their profits. It identifies Bank of America (BAC), JPMorgan (JPM), Citizens Financial (CFG),M&T Bank (MTB), and Regions Financial (RF) as being among the banks most likely to benefit from short-term rate increases.
12/15/16
BOFA
12/15/16
DOWNGRADE
BOFA
Underperform
M&T Bank downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded M&T Bank to Underperform saying its earnings upside relative to peers is lower given flat balance sheet growth, high cash balances, and flat fee income growth.
MAIN Main Street
$36.99

-0.01 (-0.03%)

02/27/17
RAJA
02/27/17
DOWNGRADE
RAJA
Market Perform
Main Street downgraded to Market Perform from Outperform at Raymond James
01/20/17
01/20/17
DOWNGRADE
Target $37

Market Perform
Main Street downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Christopher Nolan downgraded Main Street Capital to Market Perform with a $37 price target citing valuation.
02/27/17
02/27/17
DOWNGRADE

Market Perform
Main Street downgraded to Market Perform on valuation at Raymond James
As previously reported, Raymond James downgraded Main Street to Market Perform from Outperform. Analyst Robert Dodd changed his views to reflect valuation and does not see further multiple expansion in the near-term.
01/09/17
BARD
01/09/17
DOWNGRADE
Target $37
BARD
Neutral
Main Street downgraded to Neutral at Baird
As previously reported, Baird analyst Bryce Rowe downgraded Main Street Capital to Neutral from Outperform. The analyst said he sees limited upside from his price target. Rowe maintained his $37 price target on Main Street shares.
BPOP Popular
$42.77

-0.8 (-1.84%)

11/22/16
BTIG
11/22/16
DOWNGRADE
BTIG
Neutral
Popular downgraded to Neutral from Buy at BTIG
11/22/16
BTIG
11/22/16
DOWNGRADE
BTIG
Neutral
Popular downgraded based on valuation at BTIG
As noted earlier, BTIG downgraded Popular to Neutral from Buy. Analyst Mark Palmer downgraded the stock based on valuation.
01/25/17
KBWI
01/25/17
DOWNGRADE
Target $46
KBWI
Market Perform
Popular downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Brian Klock downgraded Popular to Market Perform on valuation following the company's Q4 results. The analyst raised his price target for the shares to $46 from $44.
11/18/16
COMP
11/18/16
DOWNGRADE
Target $43
COMP
Neutral
Popular downgraded to Neutral from Buy at Compass Point
Compass Point analyst Scott Valentin downgraded Popular to Hold and raised its price target to $43 from $39 on valuation and said Trumps victory has pushed bank stocks to new near-term highs.

TODAY'S FREE FLY STORIES

02:35
11/23/17
11/23
02:35
11/23/17
02:35
General news
FX Update: The dollar has remained on a downward path »

FX Update: The dollar…

L

Loews

$49.36

-0.02 (-0.04%)

, GE

General Electric

$18.15

0.32 (1.79%)

18:41
11/22/17
11/22
18:41
11/22/17
18:41
Hot Stocks
Loews CEO James Tisch buys 3M shares of General Electric »

In a regulatory filing,…

L

Loews

$49.36

-0.02 (-0.04%)

GE

General Electric

$18.15

0.32 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRFS

BRF S.A.

$12.77

-0.16 (-1.24%)

18:06
11/22/17
11/22
18:06
11/22/17
18:06
Hot Stocks
BRF S.A. names Jose Aurelio Drummond Jr. as CEO »

BRF S.A. hereby informs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$35.42

0.2 (0.57%)

18:02
11/22/17
11/22
18:02
11/22/17
18:02
Hot Stocks
Suncor closes sale of equity interest in East Tan Farm, redeems $750M in debt »

Suncor successfully…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SAP

SAP

$113.85

-1.44 (-1.25%)

17:53
11/22/17
11/22
17:53
11/22/17
17:53
Periodicals
SAP launches investigation of sales practices in Gulf region, Reuters reports »

SAP has launched a formal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$180.87

-0.99 (-0.54%)

17:47
11/22/17
11/22
17:47
11/22/17
17:47
Periodicals
Facebook tool to show users which content was Russian propaganda, says Bloomberg »

Facebook will add a tool…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$51.01

0.79 (1.57%)

17:24
11/22/17
11/22
17:24
11/22/17
17:24
Periodicals
CSX to charge more fees on customers that disregard shipping rules, Reuters says »

Starting on January 1st,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AYTU

Aytu BioScience

$3.03

0.4301 (16.54%)

17:10
11/22/17
11/22
17:10
11/22/17
17:10
Syndicate
Breaking Syndicate news story on Aytu BioScience »

Aytu BioScience files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPIX

ESSA Pharma

$0.27

0.0059 (2.27%)

17:09
11/22/17
11/22
17:09
11/22/17
17:09
Hot Stocks
ESSA Pharma to begin trading on TSX Venture Exchange »

ESSA Pharma is listing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRDN

Meridian Waste Solutions

$1.69

0.0101 (0.60%)

16:55
11/22/17
11/22
16:55
11/22/17
16:55
Syndicate
Breaking Syndicate news story on Meridian Waste Solutions »

Meridian Waste Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$161.62

-0.67 (-0.41%)

16:50
11/22/17
11/22
16:50
11/22/17
16:50
Syndicate
Breaking Syndicate news story on Air Products »

Air Products files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOT

Boot Barn

$13.49

-0.23 (-1.68%)

16:49
11/22/17
11/22
16:49
11/22/17
16:49
Syndicate
Breaking Syndicate news story on Boot Barn »

Boot Barn files $300M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$17.50

0.88 (5.29%)

, BCEI

Bonanza Creek

$32.14

0.46 (1.45%)

16:44
11/22/17
11/22
16:44
11/22/17
16:44
Hot Stocks
Icahn reports 13.51% stake in SandRidge Energy, intends to vote against Bonanza »

Icahn has read Fir Tree…

SD

SandRidge Energy

$17.50

0.88 (5.29%)

BCEI

Bonanza Creek

$32.14

0.46 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$17.50

0.88 (5.29%)

16:35
11/22/17
11/22
16:35
11/22/17
16:35
Hot Stocks
Icahn reports 13.51% stake in SandRidge Energy, intends to vote against Bonanza »

Icahn agrees with Fir…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$28.43

0.32 (1.14%)

, AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

16:32
11/22/17
11/22
16:32
11/22/17
16:32
Hot Stocks
Symantec selects Amazon Web Services to deliver cloud security »

Amazon Web Services, an…

SYMC

Symantec

$28.43

0.32 (1.14%)

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

16:30
11/22/17
11/22
16:30
11/22/17
16:30
Options
Preliminary option volume of 13.6M today »

Preliminary option volume…

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

16:26
11/22/17
11/22
16:26
11/22/17
16:26
Hot Stocks
Amazon Web Services announces Amazon ML Solutions Lab program »

Amazon Web Services, Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

NRIM

Northrim BanCorp

$34.75

-0.25 (-0.71%)

16:22
11/22/17
11/22
16:22
11/22/17
16:22
Hot Stocks
Northrim BanCorp announces CFO transition »

Northrim BanCorp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

, CERN

Cerner

$70.03

3.35 (5.02%)

16:21
11/22/17
11/22
16:21
11/22/17
16:21
General news
On The Fly: Top stock stories for Wednesday »

Stocks opened in positive…

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

CERN

Cerner

$70.03

3.35 (5.02%)

HPE

HP Enterprise

$13.10

-1.02 (-7.22%)

HPQ

HP Inc.

$21.34

-1.12 (-4.99%)

DE

Deere

$145.25

6.02 (4.32%)

ROK

Rockwell Automation

$191.02

-2 (-1.04%)

EMR

Emerson

$61.88

1.53 (2.54%)

AKZOY

AkzoNobel

$31.04

0.475 (1.55%)

AXTA

Axalta Coating

$35.50

1.63 (4.81%)

GME

GameStop

$17.37

0.64 (3.83%)

GES

Guess

$15.62

-2.33 (-12.98%)

IRBT

iRobot

$68.50

-4.57 (-6.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 11

    Dec

  • 18

    Mar

CHMI

Cherry Hill Mortgage

$18.51

0.06 (0.33%)

16:21
11/22/17
11/22
16:21
11/22/17
16:21
Syndicate
Breaking Syndicate news story on Cherry Hill Mortgage »

Cherry Hill Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$49.75

-0.23 (-0.46%)

16:20
11/22/17
11/22
16:20
11/22/17
16:20
Hot Stocks
Nektar names new CRDO, CMO and CSO »

Nektar announced several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
11/22/17
11/22
16:20
11/22/17
16:20
Options
Closing CBOE SPX and VIX Index summary for November 22nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.68

0.0069 (1.03%)

16:18
11/22/17
11/22
16:18
11/22/17
16:18
Syndicate
Vista Gold enters $10M ATM agreement with H.C. Wainwright & Co. »

Vista Gold announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$23.50

-0.2 (-0.84%)

16:17
11/22/17
11/22
16:17
11/22/17
16:17
Hot Stocks
GP Strategies announces $10M share repurchase increase »

GP Strategies Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

$NSD

NASDAQ Market Internals

16:17
11/22/17
11/22
16:17
11/22/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.